KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio (2018 - 2025)

Vertex Pharmaceuticals has reported Interest Coverage Ratio over the past 10 years, most recently at 365.42 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 365.42 for Q4 2025, changed 0.27% from a year ago — trailing twelve months through Dec 2025 was 313.78 (up 4222.68% YoY), and the annual figure for FY2025 was 313.78, up 4222.68%.
  • Interest Coverage Ratio for Q4 2025 was 365.42 at Vertex Pharmaceuticals, up from 359.45 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for VRTX hit a ceiling of 366.43 in Q4 2024 and a floor of 355.02 in Q2 2024.
  • Median Interest Coverage Ratio over the past 3 years was 148.84 (2024), compared with a mean of 163.27.
  • Peak annual rise in Interest Coverage Ratio hit 292.93% in 2024, while the deepest fall reached 487.4% in 2024.
  • Vertex Pharmaceuticals' Interest Coverage Ratio stood at 93.25 in 2023, then surged by 292.93% to 366.43 in 2024, then dropped by 0.27% to 365.42 in 2025.
  • The last three reported values for Interest Coverage Ratio were 365.42 (Q4 2025), 359.45 (Q3 2025), and 311.11 (Q2 2025) per Business Quant data.